Pacira BioSciences Inc (PCRX)
Pacira BioSciences is a holding company. Through its subsidiaries, Co. is focused on non-opioid pain management. Co. has three commercialized non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesic approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, corticosteroid injection indicated for the management of OA knee pain; and iovera°®, a handheld device for delivering immediate, long-acting, drug-free pain control using controlled doses of cold temperature to a targeted nerve.
PCRX SEC Filing Email Alerts Service
PCRX SEC Filing Email Alerts Service
|
Free PCRX Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Strong Buy (3.70 out of 4) 68th percentile
(ranked higher than approx. 68% of all stocks covered)
Analysts' Target Price: PCRX Stock Forecast Based on Zacks ABR data; powered by Xignite |